A pharmaceutical composition comprising: 3-(1-{3-[5-(1-methyl-piperidin-4-ylmethoxy)-pyrimidin-2-yl]-benzyl}-6-oxo-1,6-dihydro-pyridazin-3-yl)- benzonitrile or a pharmaceutically acceptable salt and/or solvate thereof and N-((S)-2,3-dihydroxy-propyl)-3-(2-fluoro-4-iodo-phenylamino)-isonicotinamide or a pharmaceutically acceptable salt and/or solvate thereof.Linvention concerne une composition pharmaceutique contenant : 3-(1-{3-[5-(1-méthyl-pipéridin-4-ylméthoxy)-pyrimidin-2-yl]-benzyl}-6-oxo-1,6-dihydro-pyridazin-3-yl)- benzonitrile ou un sel et/ou solvate pharmaceutiquement acceptable de celui-ci et N-((S)-2,3-dihydroxy-propyl)-3-(2-fluoro-4-iodo-phénylamino)-isonicotinamide ou un sel et/ou solvate pharmaceutiquement acceptable de celui-ci.
